Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets finished dosage forms, APIs, and Chinese herbal drugs; it focuses on generic drugs for anti-infective, cardiovascular, and cerebrovascular diseases, including hypertension, hyperlipemia, hyperglycemia, and antiplatelet coagulating; and central nervous system, such as antidepressant, antipsychotic, antiparkinsonian, anti-alzheimer's disease, sedative-hypnotic, and anticonvulsant.
Ticker:
002020
ISIN:
CNE000001K73
Address:
No. 800 Xinchang Eas (click to copy or hover over here to view full address)
CSRHub includes data on World Council for Sustainable Business Development, Business ethics, Diversity & Labor Rights, epa, Sustainability, and Governance.